Bunnag, P <br/><br/>
Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas.  [electronic resource] 

 -  Diabetes research and clinical practice  Feb 2001 
 - 151-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8227(00)00218-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>Blood Pressure<br/>Body Mass Index<br/>C-Peptide--blood<br/>Chromans--therapeutic use<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Therapy, Combination<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--blood<br/>Middle Aged<br/>Sulfonylurea Compounds--therapeutic use<br/>Thailand<br/>Thiazoles--therapeutic use<br/>Thiazolidinediones<br/>Time Factors<br/>Troglitazone